Refine by
Lithotripsy Articles & Analysis
14 news found
(NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, has initiated the first-ever prospective coronary intervention study consisting of all female patients – EMPOWER CAD – to determine whether the positive results from earlier coronary IVL studies with the Shockwave C2 Coronary IVL ...
(NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that the company will be participating in two upcoming virtual investor conferences: The 2022 Wells Fargo Healthcare Conference Fireside Chat on Thursday, September 8, 2022, at 9:10 a.m. ...
(NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that the company will be participating in two upcoming virtual investor conferences: The 2022 Wells Fargo Healthcare Conference Fireside Chat on Thursday, September 8, 2022, at 9:45 a.m. ...
Looking forward to @Urovivo2022, the most outstanding urology course in Argentina and live flexible ureteroscopic lithotripsy by Prof. Evangelos Liatsikos with #PUSEN leading & advanced 7.5Fr ureteroscope. ...
Lite-Med’s Extracorporeal Shock Wave Lithotripter (ESWL) LM-9200ELMA (who won the 2018 Taiwan Excellence Award) was exhibited at the MEDICA Taiwan Excellence Exhibit in Germany. At the exhibition, Lite-Med received high priase from medical experts from Europe, North Africa and Central Asia. Lite-Med General Manager Walt Hsu was invited to an exclusive interview with local media. This is an ...
SANUWAVE Health, Inc. (OTCQB:SNWV), a leading provider of next-generation advanced wound care medical systems for the repair and regeneration of skin and vascular structures and the research for new applications for shockwave systems in the non-medical field, announced today the patent activity for the full year 2020 and the first quarter of ...
(NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, and Genesis MedTech Group announced today that they have successfully obtained approval from China’s National Medical Products Administration (NMPA) to market and sell the Shockwave IVL System with the Shockwave C2 Coronary IVL Catheters and ...
(NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that long-term data from the Disrupt PAD III trial found that superior vessel preparation with IVL led to excellent long-term outcomes out to two years with preservation of future treatment options compared to percutaneous ...
(NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today new data confirming excellent one-year outcomes with coronary IVL in both women and men. ...
(NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, today announced the global commercial availability of the Shockwave M5+ peripheral IVL catheter after receiving both CE Mark and U.S. ...
Godshall serves as President, Chief Executive Officer and Director of Shockwave Medical, a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease. He is also a member of the Board of Directors of the Medical Device Manufacturers Association and Chairman of the Board of Gala Therapeutics, a privately ...
Lite-Med collaborated with UAA and shared the case study results of LM-9200ELMA and LM-IASO at conference of urological disease treatment using extracoporeal shock wave lithotripsy (ESWL) at Royal Phnom Penh Hospital, Cambodia, January 2019. ...
Taiwan’s Industrial Image Publicity Plan promotes Taiwan excellence products in Japanese market. Lite-Med’s extracorporeal shock wave lithotripter, which is a Taiwanese medical product, is honored to be included in this issue of Japanese and English Mook, to promote Taiwanese Excellence award-winning products in Japanese and global market. ...
Lite-Med was invited to an interview with Taiwan TV show “Trully Seeing Taiwan”, CTI TV. This is a confirmation of Lite-Med’s success in developing extracorporeal shock wave lithotripter (ESWL), transforming the existing Taiwan existing medical device market to use locally manufacutred devices. Lite-Med’s ESWL strengthens in the exclusive MIT dual-position tracking and ...